Chimeric Therapeutics
Chimeric Therapeutics

Chimeric Therapeutics Information

Contact top employees from Chimeric Therapeutics

Summary

Chimeric Therapeutics is the ASX leader in cell therapy.

As the only clinical stage, cell therapy biotechnology company in Australia, our focus is on discovering, developing and commercia...Show more

Organization Website

chimerictherapeutics.com

Social Links

linkedIntwitter

Phone Number

+61 3 9824 5254

Industries

Headquarters Location

62 Lygon St, Carlton, Victoria, 3053 AU

Employees Size

1-10 employees

Specialties

Cell Therapy, Immunotherapy, Immunooncology, Biotechnology, Biotech, Cancer Research, Life Sciences, drug development

Founded

2020

Employees Turnover 4 quarter 2025

Length of Employment
arrow
Employee tenure at Chimeric Therapeutics shows a diverse range of experience levels:
43% for 1–2 years29% for 3–4 years29% for 5–7 years
Contact top employees from Chimeric Therapeutics
Cassandra
Vice President of Clincal Operations and Data Management
View
Li Ren
VP, Head of Technical Operations
View
Rebecca McQualter
Chief Executive Officer
View
Jason Litten
Chief Medical Officer
View
Agathe Bourgogne
Executive Director, CMC
View
Stephanie Astrow
Chief Scientific Officer
View

FAQ

Chimeric Therapeutics operates in the Biotech industries. More details can be found on the official website: chimerictherapeutics.com.
The headquarters of Chimeric Therapeutics are located in Carlton, Australia.
You can contact Chimeric Therapeutics by phone at +61 3 9824 5254.
Chimeric Therapeutics currently employs 1-10 people.

Data Privacy

GDPR Icon

GDPR COMPLIANT

SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.

CCPA Icon

CCPA COMPLIANT

SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.

BACK TO TOP